Jialin Pharmaceutical

Company Overview Beijing Jialin Pharmaceutical Co., Ltd. was registered and established in Beijing in December 1998. In 2009, Jialin Pharmaceutical was already among the top 200 pharmaceutical enterprises in China. The company's main business scope includes: manufacturing chemical active pharmaceutical ingredients, tablets, capsules, etc., while also carrying out technical development, technical consulting, technical services, and technology transfer for pharmaceutical and biological products; operating the products of the company and its member enterprises as well as import and export business. R&D Strength The company regards technological innovation as the foundation of its existence and places great emphasis on new drug R&D. Currently, the research institute boasts a scientific research and development team of dozens of personnel, mainly consisting of doctors, masters, and senior engineers, with divisions for pharmaceutical chemical synthesis, pharmaceutical preparations, pharmacology, and analytical testing. This forms a research pattern focusing on cardiovascular, endocrine, and anti-tumor drugs, featuring statin lipid-lowering drugs, dihydropyridine calcium antagonists, and oral traditional formulations alongside modern sustained-release and controlled-release drug delivery systems. Since the establishment of the institute in 1998, it has successfully developed 8 new class II drugs and nearly 20 class IV new drugs, obtaining dozens of new drug certificates, including atorvastatin calcium, mizolastine, and other exclusive varieties with high technical content and strong market competitiveness. Production Quality Management For comprehensive and scientific drug production management, the company invested over 50 million RMB in early 2000 to build, on the basis of the original factory, an oral solid dosage form workshop, an anti-tumor drug workshop, a refining, drying, and packaging workshop, an automated high-bay warehouse for drugs supporting production and research, and a central laboratory, all meeting national GMP standards. In 2001, it passed GMP certification, and in 2009, it passed re-certification for all dosage forms and varieties. The factory covers an area of 41,573 square meters, with a building area of 13,086 square meters. Annual production capacity: 1 billion tablets, 200 million capsules, 5 million sachets of granules, and 9 tons of active pharmaceutical ingredients. Through years of unremitting efforts, Jialin Pharmaceutical has entered a phase of standardized, innovative, and high-speed development, providing millions of patients with high-quality and reliable medicines. Professional Marketing According to the company's strategic development plan, Jialin Pharmaceutical is committed to building a high-level professional team skilled in cardiovascular drug marketing. Establishing 'Ale' as the leading lipid-lowering drug brand in China and making Ale and subsequent products the top brand in the domestic cardiovascular drug market is the aspiration of the Jialin people. The company has established over 30 offices in major cities across the country, with hundreds of professional sales personnel. By organizing various forms of academic conferences, it has strengthened academic exchanges among clinicians on cardiovascular and cerebrovascular diseases, greatly enhancing the level of primary-level doctors' understanding of cardiovascular and cerebrovascular diseases and the standardization of medication. Jialin Employee Benefits 1. Salary income, bonus income, and benefits. 2. Company shuttle bus, cafeteria, social insurance and housing fund, annual leave, and statutory public holidays. 3. Annual physical examination, subsidies, and other benefits.